Fuqua SA - Search Results

1

Selective estrogen receptor modulators: structure, function, and clinical use.

Osborne CK, Zhao H, Fuqua SA. Osborne CK, et al. Among authors: fuqua sa. J Clin Oncol. 2000 Sep;18(17):3172-86. doi: 10.1200/JCO.2000.18.17.3172. J Clin Oncol. 2000. PMID: 10963646 Review.

2

Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.

Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K, Marshall M, Li CH. Osborne CK, et al. Among authors: fuqua sa. Mol Endocrinol. 1989 Nov;3(11):1701-9. doi: 10.1210/mend-3-11-1701. Mol Endocrinol. 1989. PMID: 2558302

3

Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model.

Osborne CK, Ross CR, Coronado EB, Fuqua SA, Kitten LJ. Osborne CK, et al. Among authors: fuqua sa. Breast Cancer Res Treat. 1988 Jul;11(3):211-9. doi: 10.1007/BF01807279. Breast Cancer Res Treat. 1988. PMID: 3167228

4

Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK, Waldman FM. Isola JJ, et al. Among authors: fuqua sa. Am J Pathol. 1995 Oct;147(4):905-11. Am J Pathol. 1995. PMID: 7573366 Free PMC article.

5

Immunohistochemical studies of early breast cancer evolution.

Allred DC, O'Connell P, Fuqua SA, Osborne CK. Allred DC, et al. Among authors: fuqua sa. Breast Cancer Res Treat. 1994;32(1):13-8. doi: 10.1007/BF00666202. Breast Cancer Res Treat. 1994. PMID: 7819582 Review.

6

Mechanisms of tamoxifen resistance.

Osborne CK, Fuqua SA. Osborne CK, et al. Among authors: fuqua sa. Breast Cancer Res Treat. 1994;32(1):49-55. doi: 10.1007/BF00666205. Breast Cancer Res Treat. 1994. PMID: 7819585 Review.

7

Molecular genetic studies of early breast cancer evolution.

O'Connell P, Pekkel V, Fuqua S, Osborne CK, Allred DC. O'Connell P, et al. Breast Cancer Res Treat. 1994;32(1):5-12. doi: 10.1007/BF00666201. Breast Cancer Res Treat. 1994. PMID: 7819586 Review.

8

Heat shock proteins and drug resistance.

Fuqua SA, Oesterreich S, Hilsenbeck SG, Von Hoff DD, Eckardt J, Osborne CK. Fuqua SA, et al. Breast Cancer Res Treat. 1994;32(1):67-71. doi: 10.1007/BF00666207. Breast Cancer Res Treat. 1994. PMID: 7819588 Review.

9

The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer.

Stein D, Wu J, Fuqua SA, Roonprapunt C, Yajnik V, D'Eustachio P, Moskow JJ, Buchberg AM, Osborne CK, Margolis B. Stein D, et al. Among authors: fuqua sa. EMBO J. 1994 Mar 15;13(6):1331-40. doi: 10.1002/j.1460-2075.1994.tb06386.x. EMBO J. 1994. PMID: 7907978 Free PMC article.

10

Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.

Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, Chamness GC, Osborne CK. Ravdin PM, et al. Among authors: fuqua sa. J Clin Oncol. 1994 Mar;12(3):467-74. doi: 10.1200/JCO.1994.12.3.467. J Clin Oncol. 1994. PMID: 8120545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters